“I have found the National Foundation for Cancer Research team to be dedicated and caring, I have been treated as part of their family. I feel privileged to have met them. I know that one day my fine and dedicated family will find a cure for glioblastoma and many other…...
The First Successful Clinical Trial
Clinical Trial and translational medicine. Our CEO and son of the Founder of NFCR likes to talk history. Franklin C. Salisbury, Jr. notes the coincidence, perhaps, that the Salisbury name has long been associated with unheralded basic research that leads to major breakthroughs. Clinical trial and translational medicine – bring…...
Breast Cancer Treatments in the News
New Treatments Could Shrink Breast Cancer in Just 11 Days For patients with HER2-positive breast cancer, a new combination therapy with two drugs could shrink or even eliminate their tumors in just 11 days. About 10% of breast cancers are HER2-positive, which is a subtype of breast cancer that is aggressive…...
2016 Szent-Györgyi Prize for Progress in Cancer Research
Mary-Claire King, Ph.D. of University of Washington Awarded 2016 Szent-Györgyi Prize for Progress in Cancer Research (Bethesda, MD – January 21, 2016) The National Foundation forCancer Research (NFCR) announced today that Mary-Claire King, Ph.D., University of Washington professor of medicine (medical genetics) and genome sciences has been awarded the 2016 Szent-Györgyi…...
Dr. Daniel Von Hoff Honored with Scripps Genomic Medicine Award
Dr. Daniel Von Hoff was presented this month with the Scripps Genomic Medicine Award for his “pioneering efforts” in sequencing, or spelling out, the DNA of patients with rare cancers. Dr. Von Hoff’s research and clinical work advances the art of using the fully sequenced genomes of cancer patients, spelling…...
Strategic Media Partner
